Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
Completed
Karuna Pharmaceuticals
Phase 1
2016-09-07
This study is intended to determine whether the addition of trospium chloride to xanomeline
tartrate will ameliorate the peripheral cholinergic side effects that have been previously
experienced with xanomeline tartrate when administered alone.
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
Completed
Karuna Therapeutics
Phase 1
2016-09-07
This study is intended to determine whether the addition of trospium chloride to xanomeline
tartrate will ameliorate the peripheral cholinergic side effects that have been previously
experienced with xanomeline tartrate when administered alone.
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NOT_YET_RECRUITING
Bristol-Myers Squibb
PHASE3
2025-11-21
The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
